Skip to content

TRIAL COMPARING THE AMOUNT OF ANESTHETIC DRUG CONSUMED AND TIME TAKEN FOR ATTAINING ADEQUATE LEVEL OF ANESTHESIA BETWEEN TWO DIFFERENT FLOW LEVELS OF FRESH GAS FOR NON-EMERGENCY SURGERIES IN CHILDREN OF 2 TO 5 YEARS AGE

A RANDOMISED SINGLE BLINDED INTERVENTIONAL STUDY COMPARING THE EFFICACY OF 2 LITRES/MIN FRESH GAS FLOW VS 6 LITRES/MIN FRESH GAS FLOW WITH 8% SEVOFLURANE FOR LMA INSERTION IN ELECTIVE SURGERIES IN CHILDREN OF 2 TO 5 YEARS AGE - LMA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032452
Enrollment
50
Registered
2021-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 2LITRES/MIN FRESH GAS FLOW WITH 8% SEVOFLURANE: VOLUME OF SEVOFLURANE CONSUMED AND TIME TAKEN FOR 2LITRES/MIN FRESH GAS FLOW WITH 8 % SEVOFLURANE DELIVERED VIA THE CIRCLE BREATHING SYS

Sponsors

DEPARTMENT OF PEDIATRIC ANESTHESIA
Lead Sponsor
DR ANURADHA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: AMERICAN SOCIETY OF ANESTHESIOLOGISTS PHYSICAL STATUS CLASSIFICATION ASA PS 1 A NORMAL HEALTHY PATIENT THAT INCLUDES(BUT NOT LIMITED TO) A HEALTHY (NO ACUTE OR CHRONIC DISEASE) CHILD WITH NORMAL BMI PERCENTILE FOR AGE ASA PS2 A PATIENT WITH MILD SYSTEMIC DISEASE THAT INCLUDES (BUT NOT LIMITED TO) CHILD WITH ASYMPTOMATIC CONGENITAL HEART DISEASE, WELL CONTROLLED DYSRHYTHMIAS,ASTHMA WITHOUT EXACERBATION, WELL CONTROLLED EPILEPSY, NON INSULIN DEPENDENT DIABETES MELLITUS, ABNORMAL BMI PERCENTILE FOR AGE ELECTIVE SURGERIES- SURGERIES THAT ARE SCHEDULED IN ADVANCE

Exclusion criteria

Exclusion criteria: PATIENTS NOT SATISFYING INCLUSION CRITERIA PATIENT/PARENT REFUSAL FOR INCLUSION INTO STUDY HISTORY OF NEUROLOGICAL CARDIOVASCULAR GENETIC DISEASES HISTORY OF RESPIRATORY ILLNESSES LIKE BRONCHIAL ASTHMA CHILDREN WITH ANTICIPATED DIFFICULT AIRWAY CHILDREN WITH KNOWN ALLERGY TO ANESTHETIC AGENTS

Design outcomes

Primary

MeasureTime frame
VOLUME OF SEVOFLURANE CONSUMED FOR LARYNGEAL MASK AIRWAY INSERTIONTimepoint: 12 WEEKS

Secondary

MeasureTime frame
TIME TAKEN FOR LARYNGEAL MASK AIRWAY INSERTION NUMBER OF ATTEMPTS OF LARYNGEAL MASK AIRWAY INSERTION INCIDENCE OF POSTOPERATIVE SORETHROATTimepoint: 12 WEEKS

Countries

India

Contacts

Public ContactR SHRINIDHI

MADRAS MEDICAL COLLEGE

krishpaedanaes@gmail.com9444451194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026